PF-0254920
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-0254920, covering 2017-12-14 to 2017-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease [Phase 2]